Researchers have isolated antibodies from several COVID-19 patients that, to date, are among the most potent in neutralizing the SARS-CoV-2 virus. These antibodies could be produced in large quantities by pharmaceutical companies to treat patients, especially early in the course of infection, and to prevent infection, particularly in the elderly.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/07/200722083804.htm
No comments:
Post a Comment